Many people who start GLP-1 treatment for weight management see good results, but sometimes life gets in the way
Freezing can cause crystallization and alter the suspension, reducing bioavailability
But the SEMALEAN data suggests that semaglutide does not inherently destroy muscle in the way some early headlines suggested, especially when patients maintain adequate protein and physical activity
The studys data does not follow patients long enough to say what the muscle loss means over a decade of use
diet, etc
Separately, the Medicare GLP-1 Bridge launches July 1, 2026, giving eligible beneficiaries weight-loss access to Wegovy at $50/month through December 31, 2027 this operates outside Part D, so the $50 does not count toward the $2,100 OOP cap or TrOOP